Evidence map›Paper›PMID 39810894›Full record

ArticleEJIFCC2024

Light After Armageddon: Enhancing Cardiovascular Care through Emerging Technologies and Patient-Centric Approaches.

Damien Gruson, Chiara Peranio, Sergio Bernardini, Aistė Štaraitė, Mikki Koo, Mike Coyle, Bryan Shannon, David Luu, Ed Harding, Tuğba Kemaloğlu Öz

Abstract read
PubMed Full text at PMC
In one paragraph

Article in EJIFCC, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Damien GrusonDepartment of Laboratory Medicine, Cliniques Universitaires St-Lux, Brussels, Belgium and Université Catholique de Louvain, Brussels, Belgium.
Chiara PeranioCommunication and digital Marketing, University Mercatorum, Roma, Italy.
Sergio BernardiniDepartment. of Experimental Medicine, University of Tor Vergata, Roma, Italy.
Aistė ŠtaraitėGlobal Heart Hub, The International Alliance of Heart Patient Organisations.
Mikki KooRoche Diagnostics International, Switzerland.
Mike CoyleRoche Diagnostics International, Switzerland.
Bryan ShannonParadigmDx, Carlsbad, California, USA.
David LuuThe Heart Fund, Paris, France.
Ed HardingHealth Policy Partnership, London, United Kingdom.
Tuğba Kemaloğlu ÖzAlice Springs Hospital, Alice Springs, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

artificial intelligencebiomarkersCardiovascular diseasesemerging technologiesprevention

Identifiers

PMID39810894
PMCPMC11726328

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.